Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?

Detalhes bibliográficos
Autor(a) principal: Scuarcialupi, Maria Enedina Aquino
Data de Publicação: 2014
Outros Autores: Berton, Danilo Cortozi, Cordoni, Priscila Kessar, Squassoni, Selma Denis, Fiss, Elie, Neder, Jose Alberto [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S1806-37132014000200003
http://repositorio.unifesp.br/handle/11600/44158
Resumo: Objective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise.
id UFSP_7e83025b5b9f71417c71ea57634b339c
oai_identifier_str oai:repositorio.unifesp.br/:11600/44158
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?Pulmonary diseasechronic obstructiveBronchodilator agentsExercise testExercise toleranceInspiratory capacityObjective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise.Fac Ciencias Med Paraiba, Joao Pessoa, Paraiba, BrazilUniv Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, BrazilFac Med ABC, Disciplina Pneumol, Santo Andre, SP, BrazilFac Med ABC, Disciplina Pneumol, Setor Reabilitacao Pulmonar, Santo Andre, SP, BrazilQueens Univ, Div Resp & Crit Care Med, Kingston, ON, CanadaKingston Gen Hosp, Kingston, ON, CanadaUniv Fed Sao Paulo, Sao Paulo, BrazilUniv Fed Sao Paulo, Sao Paulo, BrazilWeb of ScienceSoc Brasileira Pneumologia TisiologiaFac Ciencias Med ParaibaUniv Fed Rio Grande do SulFac Med ABCQueens UnivKingston Gen HospUniversidade Federal de São Paulo (UNIFESP)Scuarcialupi, Maria Enedina AquinoBerton, Danilo CortoziCordoni, Priscila KessarSquassoni, Selma DenisFiss, ElieNeder, Jose Alberto [UNIFESP]2018-06-15T17:49:55Z2018-06-15T17:49:55Z2014-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion111-118http://dx.doi.org/10.1590/S1806-37132014000200003Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014.10.1590/S1806-37132014000200003S1806-37132014000200111-en.pdfS1806-37132014000200111-pt.pdf1806-3713S1806-37132014000200111http://repositorio.unifesp.br/handle/11600/44158WOS:000334569100003porJornal Brasileiro De Pneumologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-02T15:58:50Zoai:repositorio.unifesp.br/:11600/44158Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-02T15:58:50Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
title Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
spellingShingle Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
Scuarcialupi, Maria Enedina Aquino
Pulmonary disease
chronic obstructive
Bronchodilator agents
Exercise test
Exercise tolerance
Inspiratory capacity
title_short Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
title_full Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
title_fullStr Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
title_full_unstemmed Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
title_sort Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
author Scuarcialupi, Maria Enedina Aquino
author_facet Scuarcialupi, Maria Enedina Aquino
Berton, Danilo Cortozi
Cordoni, Priscila Kessar
Squassoni, Selma Denis
Fiss, Elie
Neder, Jose Alberto [UNIFESP]
author_role author
author2 Berton, Danilo Cortozi
Cordoni, Priscila Kessar
Squassoni, Selma Denis
Fiss, Elie
Neder, Jose Alberto [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Fac Ciencias Med Paraiba
Univ Fed Rio Grande do Sul
Fac Med ABC
Queens Univ
Kingston Gen Hosp
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Scuarcialupi, Maria Enedina Aquino
Berton, Danilo Cortozi
Cordoni, Priscila Kessar
Squassoni, Selma Denis
Fiss, Elie
Neder, Jose Alberto [UNIFESP]
dc.subject.por.fl_str_mv Pulmonary disease
chronic obstructive
Bronchodilator agents
Exercise test
Exercise tolerance
Inspiratory capacity
topic Pulmonary disease
chronic obstructive
Bronchodilator agents
Exercise test
Exercise tolerance
Inspiratory capacity
description Objective: To investigate the modulatory effects that dynamic hyperinflation (UFO, defined as a reduction in inspiratory capacity (lC), has on exercise tolerance after bronchodilator in patients with COPD. Methods: An experimental, randomized study involving 30 COPD patients without severe hypoxemia. At baseline, the patients underwent clinical assessment, spirometry, and incremental cardiopulmonary exercise testing (CPET). On two subsequent visits, the patients were randomized to receive a combination of inhaled fenoterol/ipratropium or placebo. All patients then underwent spirometiy and submaximal CPET at constant speed up to the limit of tolerance (Tlim). The patients who showed Delta lC(peak-rest) < 0 were considered to present with DH (DH+). Results: In this sample, 21 patients (70%) had DH. The DH+ patients had higher airflow obstruction and lower Tlim than did the patients without Did (DH-). Despite equivalent improvement in FEV1 after bronchodilator, the DH- group showed higher Delta lC(bronchodilator-placebo) at rest in relation to the DH+ group (p < 0.05). However, this was not found in relation to Delta lC at peak exercise between DH+ and DH- groups (0.19 +/- 0.17 L vs. 0.17 +/- 0.15 L, p > 0.05). in addition, both groups showed similar improvements in Tlim after bronchodilator (median [interquartile range]: 22% [3-60% vs. 10% [3-53%]; p > 0.05). Conclusions: Improvement in TLim was associated with an increase in lC at rest after bronchodilator in HD- patients with COPD. However, even without that improvement, COPD patients can present with greater exercise tolerance after bronchodilator provided that they develop DH during exercise.
publishDate 2014
dc.date.none.fl_str_mv 2014-03-01
2018-06-15T17:49:55Z
2018-06-15T17:49:55Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S1806-37132014000200003
Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014.
10.1590/S1806-37132014000200003
S1806-37132014000200111-en.pdf
S1806-37132014000200111-pt.pdf
1806-3713
S1806-37132014000200111
http://repositorio.unifesp.br/handle/11600/44158
WOS:000334569100003
url http://dx.doi.org/10.1590/S1806-37132014000200003
http://repositorio.unifesp.br/handle/11600/44158
identifier_str_mv Jornal Brasileiro De Pneumologia. Brasilia Df: Soc Brasileira Pneumologia Tisiologia, v. 40, n. 2, p. 111-118, 2014.
10.1590/S1806-37132014000200003
S1806-37132014000200111-en.pdf
S1806-37132014000200111-pt.pdf
1806-3713
S1806-37132014000200111
WOS:000334569100003
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Jornal Brasileiro De Pneumologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 111-118
dc.publisher.none.fl_str_mv Soc Brasileira Pneumologia Tisiologia
publisher.none.fl_str_mv Soc Brasileira Pneumologia Tisiologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268403058212864